| 生物活性 | |||
|---|---|---|---|
| 描述 | CAY10746 is a selective Rho kinase (ROCK) inhibitor, displaying inhibitory activity towards ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively, and is researched for its potential in treating diabetic retinopathy (DR) [1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.19mL 0.44mL 0.22mL |
10.93mL 2.19mL 1.09mL |
21.86mL 4.37mL 2.19mL |
| 参考文献 |
|---|